Maryam Vasefi

Dr. Maryam Vasefi


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Neurochemistry International
Verified
Journal Article
Closed access
MVMaryam Vasefi
Maryam Vasefi
EGEhsan Ghaboolian-Zare
Ehsan Ghaboolian-Zare
HAHamzah Abedelwahab
Hamzah Abedelwahab
AOAnthony Osu
Anthony Osu

20 November 2023 in Biology
Verified
Journal Article
Open access
PDF file
CAClaire Alexander
Claire Alexander
APAli Parsaee
Ali Parsaee
MVMaryam Vasefi
Maryam Vasefi
Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder impairing cognition and memory in the elderly. This disorder has a complex etiology, including senile plaque and neurofibrillary tangle formation, neuroinflammation, oxidative stress, and damaged neuroplasticity. Current treatment options are limited, so alternative treatments such as herbal medicine could suppress symptoms while slowing cognitive decline. We followed PRISMA guidelines to identify potential herbal treatments, their associated medicinal phytochemicals, and the potential mechanisms of these treatments. Common herbs, including Ginkgo biloba, Camellia sinensis, Glycyrrhiza uralensis, Cyperus rotundus, and Buplerum falcatum, produced promising pre-clinical results. These herbs are rich in kaempferol and quercetin, flavonoids with a polyphenolic structure that facilitate multiple mechanisms of action. These mechanisms include the inhibition of Aβ plaque formation, a reduction in tau hyperphosphorylation, the suppression of oxidative stress, and the modulation of BDNF and PI3K/AKT pathways. Using pre-clinical findings from quercetin research and the comparatively limited data on kaempferol, we proposed that kaempferol ameliorates the neuroinflammatory state, maintains proper cellular function, and restores pro-neuroplastic signaling. In this review, we discuss the anti-AD mechanisms of quercetin and kaempferol and their limitations, and we suggest a potential alternative treatment for AD. Our findings lead us to conclude that a polyherbal kaempferol- and quercetin-rich cocktail could treat AD-related brain damage.

21 August 2021 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
CAClaire Alexander
Claire Alexander
MVMaryam Vasefi
Maryam Vasefi
Post-Traumatic Stress Disorder (PTSD), characterized by re-experiencing, avoidance, negative affect, and impaired memory processing, may develop after traumatic events. PTSD is complicated by impaired plasticity and medial prefrontal cortex (mPFC) activity, hyperactivity of the amygdala, and impaired fear extinction. Cannabidiol (CBD) is a promising candidate for treatment due to its multimodal action that enhances plasticity and calms hyperexcitability. CBD’s mechanism in the mPFC of PTSD patients has been explored extensively, but literature on the mechanism in the dorsal raphe nucleus (DRN) is lacking. Following the PRISMA guidelines, we examined current literature regarding CBD in PTSD and overlapping symptomologies to propose a mechanism by which CBD treats PTSD via corticoraphe circuit. Acute CBD inhibits excess 5-HT release from DRN to amygdala and releases anandamide (AEA) onto amygdala inputs. By first reducing amygdala and DRN hyperactivity, CBD begins to ameliorate activity disparity between mPFC and amygdala. Chronic CBD recruits the mPFC, creating harmonious corticoraphe signaling. DRN releases enough 5-HT to ameliorate mPFC hypoactivity, while the mPFC continuously excites DRN 5-HT neurons via glutamate. Meanwhile, AEA regulates corticoraphe activity to stabilize signaling. AEA prevents DRN GABAergic interneurons from inhibiting 5-HT release so the DRN can assist the mPFC in overcoming its hypoactivity. DRN-mediated restoration of mPFC activity underlies CBD’s mechanism on fear extinction and learning of stress coping.

4 November 2022 in Sensors
Verified
Journal Article
Open access
PDF file
GTGleb V. Tcheslavski
Gleb V. Tcheslavski
MVMaryam Vasefi
Maryam Vasefi
(1) The article presents a new technique to interpret biomedical data (EEG) to assess cortical responses to continuous color/hue variations. We propose an alternative approach to analyze EEG activity evoked by visual stimulation. This approach may augment the traditional VEP analysis. (2) Considering ensembles of EEG epochs as multidimensional spatial vectors evolving over time (rather than collections of time-domain signals) and evaluating the similarity between such vectors across different EEG epochs may result in a more accurate detection of colors that evoke greater responses of the visual system. To demonstrate its suitability, the developed analysis technique was applied to the EEG data that we previously collected from 19 participants with normal color vision, while exposing them to stimuli of continuously varying hue. (3) Orange/yellow and dark blue/violet colors generally aroused better-pronounced cortical responses. The selection of EEG channels allowed for assessing the activity that predominantly originates from specific cortical regions. With such channel selection, the strongest response to the hue was observed from Parieto-Temporal region of the right hemisphere. The statistical test—Kruskal–Wallis one-way analysis of variance—indicates that the distance evaluated for spatial EEG vectors at different post-stimulus latencies generally originate from different statistical distributions with a probability exceeding 99.9% (α = 0.001).